Business Wire

NY-Z-CAPITAL-GROUP

6.2.2024 13:01:28 CET | Business Wire | Press release

Share
ZCG Announces Continued Partnership with Scuderia Ferrari

Z Capital Group (“ZCG”) today announced it has signed as a Team Partner with Scuderia Ferrari for the 2024 Formula 1 season. The commitment will continue the successful partnership between ZCG and Scuderia Ferrari that began in 2023.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240131467963/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The 2023 partnership included numerous collaborative and innovative initiatives and, during the 2024 Formula 1 season, ZCG aims to work closely with Scuderia Ferrari to expand these initiatives and find new and creative ways to engage Formula 1 fans across the globe given ZCG’s international exposure.

Scuderia Ferrari will unveil its 2024 Formula 1 car on Tuesday, February 13, 2024. As a distinguished Team Partner, ZCG will prominently display its logo on the livery throughout the 2024 Formula 1 World Championship, starting at the Bahrain Grand Prix on March 2. In addition to the logo placement, this partnership includes broader collaboration and multifaceted engagement, underscoring a joint commitment to advancing success and growth for the partnership between Scuderia Ferrari and ZCG.

“We take great pride in our relationship and look forward to continuing our support of Scuderia Ferrari and building upon the success of our partnership in the 2023 season,” said James Zenni, Founder, President, and Chief Executive Officer of ZCG. “Ferrari consistently pushes the boundaries of innovation and global expansion. ZCG shares Scuderia Ferrari’s vision for excellence and strategic growth, and we eagerly anticipate further collaboration that can bring the experience and excitement of Formula 1 to more fans around the world.”

“We are pleased to renew our partnership with ZCG, with whom we share a passion for excellence and the desire to push the boundaries of innovation, without losing sight of the values and authority that stem from decades of experience in our respective fields,” said Lorenzo Giorgetti, Chief Racing Revenue Officer of Scuderia Ferrari. “We are keen to continue working with ZCG to reach an even wider audience with which to share the unique experience of Formula 1 and the very special world of Scuderia Ferrari.”

One of the most exciting and prestigious motorsport competitions in the world, Formula 1 has surged in popularity in recent years, particularly across the United States. U.S. television viewership doubled from 2018 to 2023, with an average of 1.11 million viewers per race during the 2023 season. ZCG remains committed to supporting the growth of Formula 1 through its partnership with Scuderia Ferrari, the most successful team in the history of this sport.

About ZCG

ZCG is an industry leader comprised of private markets asset management, business consulting services, technology development and solutions.

For almost 30 years, ZCG Principals have invested tens of billions in capital and have industry leading track records in private equity and credit.

ZCG has approximately $7B of AUM in asset management and its investors are some of the largest and most sophisticated global institutional investors including pension funds, endowments, foundations, sovereign wealth funds, central banks, and insurance companies.

ZCG has a global team comprised of over 400 professionals. For more information, please visit www.zcg.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240131467963/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press release

- ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels of <30 mmol/L; Vertex on track to initiate global regulatory submissions in first half of 2026 - - Long-term 96-week interim analyses from two open-label extension studies demonstrate positive safety and efficacy profile of ALYFTREK in people with cystic fibrosis ages 6 and older -- Phase 3 data on TRIKAFTA® in children 1 to <2 years also presented; Vertex has initiated global regulatory submissions - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating

Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press release

Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built

DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press release

DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict

Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press release

Barilla continues to advance its commitment to tastier products with less sugar and salt;An investment of 30 million euros in 2025 to quadruple photovoltaic capacity across plants, as part of a €168 million five-year plan focused on energy efficiency, renewable energy and sustainable water management.Barilla continues to expand regenerative agriculture practices across its global value chain, with over 816,000 tons of raw materials sourced through the Barilla Sustainable Farming program.4,000 tons of products donated worldwide and €2 million allocated to social causes in 2025, supporting communities across Barilla’s global footprint through food donations and social initiatives. A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal oppor

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye